Last Updated: 02/12/2024

Immuno-epidemiological insights into the development of immunity to malaria and drug resistance

Objectives

The aim of this project is to better understand the maintenance and acquisition of immunity to malaria in high risk groups and attempt to elucidate how immunity can interfere with the therapeutic efficacy of antimalarials, especially in the assessment of emerging drug resistance.

Principal Institution

Burnet Institute, Australia

Principal Investigators / Focal Persons

Freya JI Fowkes

Rationale and Abstract

The over-riding hypothesis is that differences in malaria transmission will lead to differential acquisition of immunity and efficacy of malaria interventions within and between populations. Understanding immunity to malaria is pivotal to develop new interventions, to understand the effectiveness of current malaria treatment and control programs to reduce the global burden of malarial disease.

Date

Dec 2013 — Oct 2019

Total Project Funding

$640,001

Funding Details
Australian Research Council (ARC), Australia

Grant ID: 3930651
AUD 830,429
Project Site

Australia

SHARE
SHARE